Nate Ela joins UC College of Law faculty
Sociologist and legal scholar Nate Ela is joining the University of Cincinnati, with a dual appointment at the College of Law and the College of Arts and Sciences. He holds a PhD in sociology from the University of Wisconsin-Madison, a JD from Harvard Law School, and a BA in political science from Columbia University.
Professor Nate Ela
A socially committed scholar with a longstanding interest in urban agriculture, Ela’s scholarship spans property, local government, land use, and election law. He uses historical and ethnographic methods to understand how and why reformers have used property to address poverty and unemployment by reallocating rights to use idle resources. He has been published in the Fordham Urban Law Journal, Law & Social Inquiry, and Social Science History.
Previously, Ela was a visiting scholar at the American Bar Foundation. He has taught as an Instructor at Northwestern Pritzker School of Law and a Fellow at Harvard Law School. Ela’s professional experience includes work with the Chicago Food Policy Council on zoning and land tenure issues raised by urban farming; Amnesty International on human rights scenario planning for the organization’s Secretary General; and Grupo Semillas, (Bogotá, Colombia) on agriculture, human rights, food sovereignty, and trade law research.
Related Stories
UC faculty and staff among Rising Star leadership honorees
January 5, 2026
Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.